Money Concepts Capital Corp Immunity Bio, Inc. Transaction History

Money Concepts Capital Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 01, 2023	BUY	$1.35 - $4.78 $252 - $893	187 Added 0.61%	30,889 $56,000
Q4 2022 Feb 14, 2023	BUY	$4.35 - $6.77 $2,523 - $3,926	580 Added 1.93%	30,702 $155,000
Q3 2022 Oct 27, 2022	BUY	$3.65 - $6.43 $109,945 - $193,684	30,122 New	30,122 $150,000

204

70M

1.68M

1.31M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.05B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Money Concepts Capital Corp, based on Form 13F filings with the SEC.

Stay updated on Money Concepts Capital Corp with notifications on news.